Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran

Ali Reza Samarbaf-Zadeh 1 , 2 , Manochehr Makvandi 1 , 2 , Ahmad Hamadi 3 , Gholam Abbas Kaydani 1 , 4 , * , Abdorrahim Absalan 5 , Parviz Afrough 6 , Mohammad Jahangir 1 , 2 and Saeid Saeidimehr 7
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Parasitology, Iran University of Medical Sciences, Tehran, IR Iran
4 Allied Health Sciences School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
6 Department of Microbiology, Tehran University of Medical Sciences, Tehran, IR Iran
7 Department of Clinical Laboratory, Naft Grand Hospital, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 01, 2015, 8 (5); e20834
  • Published Online: May 21, 2015
  • Article Type: Research Article
  • Received: May 31, 2014
  • Revised: October 7, 2014
  • Accepted: January 6, 2015
  • DOI: 10.5812/jjm.20834

To Cite: Samarbaf-Zadeh A R, Makvandi M, Hamadi A, Kaydani G A, Absalan A, et al. Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran, Jundishapur J Microbiol. 2015 ; 8(5):e20834. doi: 10.5812/jjm.20834.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Francki RIB, Fauquet C, Knudson DL, Brown F. Classification and nomenclature of viruses. 1991;
  • 2. Westaway EG, Brinton MA, Gaidamovich S, Horzinek MC, Igarashi A, Kaariainen L, et al. Flaviviridae. Intervirology. 1985; 24(4): 183-92[PubMed]
  • 3. Gubler DJ, Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res. 1999; 53: 35-70[PubMed]
  • 4. Monath TP. Japanese encephalitis--a plague of the Orient. N Engl J Med. 1988; 319(10): 641-3[PubMed]
  • 5. Haghbin M, Murphy ML, Tan CC, Clarkson BD, Thaler HT, Passe S, et al. A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer. 1980; 46(2): 241-52[PubMed]
  • 6. Westaway E. Replication of flaviviruses. The Togaviruses. 1980; : 531-81
  • 7. Mukaide M, Mijokami M, Orito E. There are three subtypes of GB virus C/Hepatitis G virus (HGV): geographic distribution and HGV RNA levels. Hepatology. 1996; 24
  • 8. Linnen J, Wages JJ, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996; 271(5248): 505-8[PubMed]
  • 9. Bogard M, Louvet M, Kamalodine T, Barbanel C. Determination of hepatitis G virus (HGV) status in dialyzed patients: prevalence and rate of co-infection with hepatitis C virus (HCV). Hepatology. 1996; 24
  • 10. Diamantis I, Bassetti S, Erb P, Ladewig D, Gyr K, Battegay M. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol. 1997; 26(4): 794-7[PubMed]
  • 11. Feucht HH, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet. 1996; 347(9001): 615-6[PubMed]
  • 12. Forns X, Fernandez-Llama P, Costa J, Lopez-Labrador FX, Ampurdanes S, Olmedo E, et al. Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant. 1997; 12(5): 956-60[PubMed]
  • 13. Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J Aust. 1996; 165(2): 84-5[PubMed]
  • 14. Peterson J, Zheng J, Fong T, Kim J, Kochesky R, Bolta R. Prevalence and persistence of hepatitis G virus in high risk populations. Hepatology. 1996; 24
  • 15. Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol. 1999; 59(1): 38-44[PubMed]
  • 16. Noguchi S, Sata M, Suzuki H, Ohba K, Mizokami M, Tanikawa K. GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan. Virus Res. 1997; 49(2): 155-62[PubMed]
  • 17. Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, et al. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy. J Med Virol. 1998; 54(1): 26-37[PubMed]
  • 18. De Filippi F., Lampertico P., Soffredini R., Rumi MG., Lunghi G., Aroldi A., et al. . High prevalence, low pathogenicity in hepatitis G virus in kidney transplant recipients Digest Liver Dis. 2001; 33(6): 477-9
  • 19. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 1996; 348(9042): 1626-9[PubMed]
  • 20. Watanabe MA, Milanezi CM, Silva WA J, de Lucena Angulo I, Santis G, Kashima S, et al. Molecular investigation og GB virus C RNA in hemodialysis and thalassemics patients from Brazil. Ren Fail. 2003; 25(1): 67-75
  • 21. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Kao Y, Mukaide M, et al. GB virus C/hepatic G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients. J Clin Gastroenterol. 2000; 30: 425-8
  • 22. Kao, JH. , Huang, CH. , Chen, W. , Tsai, TJ. , et al. . GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission. Infect Dis J. 1999; 180(1): 191-4
  • 23. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol. 1996; 25(6): 842-7[PubMed]
  • 24. Dawson GJ, Schlauder GG, Pilot-Matias TJ, Thiele D, Leary TP, Murphy P, et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol. 1996; 50(1): 97-103[PubMed]
  • 25. Hadziyannis SJ. Fulminant hepatitis and the new G/GBV-C flavivirus. J Viral Hepat. 1998; 5(1): 15-9[PubMed]
  • 26. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996; 20(11): 1169-72[PubMed]
  • 27. Theodore D, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology. 1997; 25(5): 1285-6[DOI][PubMed]
  • 28. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet. 1998; 352(9123): 191-5[PubMed]
  • 29. Kafi-Abad SA, , Samiei S, , Talebian A, , Maghsudloo M, , Gharehbaghian A. . Hepatitis G virus infection in Iranian blood donors and high-risk groups. Hepat Mon J. 2009; 9(4): 282-6
  • 30. Samadi M, Keyvani H, Hosseini Moghaddam. SM. . Prevalence and risk factors of the hepatitis G (HGV) infection in hemodialysis patients. Arch Clinic Infect Dis. 2008; 3(1): 7-11
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments